Baxter International | BAX - Ativo Circulante





Ativo Circulante Alterar Data
Abbott USD 23.5B 1.02B 2026-09
AngioDynamics USD 161.35M 4.69M 2025-09
Artivion USD 371.38M 13.86M 2026-06
AtriCure USD 363.39M 17.86M 2026-09
Baxter International USD 6.83B 163M 2026-09
Becton, Dickinson and Co. USD 8.14B 127M 2026-06
Boston Scientific USD 8.16B 192M 2026-09
Cooper Companies USD 2.28B 18.3M 2026-06
Dexcom USD 3.92B 170.6M 2026-09
Edwards Lifesciences USD 7.25B 428.6M 2026-09
Fresenius EUR 12.29B 678M 2026-09
Globus Medical USD 2.22B 17.39M 2026-06
Halozyme Therapeutics USD 933.02M 70.01M 2026-06
ICU Medical USD 1.21B 2.34M 2026-06
Inogen USD 203.72M 594K 2025-09
Insulet USD 2.04B 192.4M 2026-09
Integra LifeSciences USD 1.19B 1.54M 2026-09
Intuitive Surgical USD 10.65B 1.68B 2026-09
J&J USD 56.35B 3.42B 2026-09
Laboratory Of America USD 3.97B 151.3M 2026-09
Medtronic USD 24.39B 397M 2026-06
Merit Medical Systems USD 1.2B 86.58M 2026-09
Quest Diagnostics USD 3.12B 273M 2026-09
Smith & Nephew USD 4.39B 240M 2026-06
Stryker USD 14.18B 235M 2026-09
Tandem Diabetes Care USD 804.64M 82.46M 2026-06
Teleflex USD 1.84B 31.2M 2026-09
Terumo JPY 906.6B 45.57B 2026-06
Zimmer Biomet Holdings USD 5.13B 32.3M 2026-09